A detailed history of Riverpark Capital Management LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Riverpark Capital Management LLC holds 4,314 shares of ZTS stock, worth $757,840. This represents 1.53% of its overall portfolio holdings.

Number of Shares
4,314
Previous 6,012 28.24%
Holding current value
$757,840
Previous $1.04 Million 19.19%
% of portfolio
1.53%
Previous 1.38%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$172.58 - $196.48 $293,040 - $333,623
-1,698 Reduced 28.24%
4,314 $842,000
Q2 2024

Jul 26, 2024

BUY
$145.54 - $178.83 $109,009 - $133,943
749 Added 14.23%
6,012 $1.04 Million
Q1 2024

May 03, 2024

BUY
$165.67 - $199.94 $65,273 - $78,776
394 Added 8.09%
5,263 $890,000
Q4 2023

Jan 11, 2024

SELL
$151.44 - $200.09 $48,763 - $64,428
-322 Reduced 6.2%
4,869 $960,000
Q3 2023

Nov 07, 2023

BUY
$167.14 - $192.77 $116,830 - $134,746
699 Added 15.56%
5,191 $903,000
Q2 2023

Jul 27, 2023

BUY
$160.94 - $186.23 $722,942 - $836,545
4,492 New
4,492 $773,000
Q1 2022

May 09, 2022

SELL
$181.39 - $234.03 $4.86 Million - $6.28 Million
-26,813 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $4.99 Million - $6.36 Million
-25,742 Reduced 48.98%
26,813 $6.54 Million
Q3 2021

Nov 15, 2021

BUY
$189.29 - $209.69 $1.31 Million - $1.45 Million
6,919 Added 15.16%
52,555 $10.2 Million
Q1 2021

May 17, 2021

BUY
$144.0 - $169.39 $317,520 - $373,504
2,205 Added 5.08%
45,636 $7.19 Million
Q4 2020

Feb 16, 2021

BUY
$157.07 - $174.35 $2.68 Million - $2.98 Million
17,091 Added 64.89%
43,431 $7.19 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $2.26 Million - $2.72 Million
16,458 Added 166.55%
26,340 $4.36 Million
Q2 2020

Aug 14, 2020

BUY
$111.92 - $142.53 $1.11 Million - $1.41 Million
9,882 New
9,882 $1.35 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Riverpark Capital Management LLC Portfolio

Follow Riverpark Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverpark Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverpark Capital Management LLC with notifications on news.